A case report of steroid resistant cardiac sarcoidosis successfully managed with methotrexate

Main Article Content

Olga Grabowska
Magdalena M Martusewicz-Boros
Dorota Piotrowska-Kownacka
Elżbieta Wiatr



Up to one fourth of sarcoidosis patients may have cardiac involvement, what is potentially a life-threatening condition and requires aggressive treatment. Corticosteroids are generally effective in cardiac sarcoidosis, however may have significant short and long term adverse effects. We present a case of a 42-year-old male, who was diagnosed with pulmonary and cardiac sarcoidosis. He was treated initially with corticosteroids and satisfactory improvement was achieved in the lungs but not in the heart. Methotrexate was added as a second line therapy, being beneficial for the heart as well as steroid sparing agent. Cardiac improvement was documented during serial CMR imaging.


Download data is not yet available.
Abstract 116 | PDF Downloads 120

Most read articles by the same author(s)